𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Empiric antibiotic use—aztreonam as a model

✍ Scribed by Stuart Levin

Book ID
115682925
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
423 KB
Volume
88
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ceftazidime and amikacin as empiric anti
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes
✍ G. Todeschini; D. Veneri; S. Carlini; G. Pizzolo; A. Ambrosetti; R. Bonesi; V. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

One hundred and seventy-one consecutive febrile episodes occurring in 130 neutropenic adult patients with hematological malignancies (mainly acute leukemia) were empirically treated with a combination antibiotic therapy consisting of ceftazidime (100 mg/kg/day) + amikacin (1 5 mg/kg/day). Of these,

Doubleβ-lactam regimen compared to an am
Doubleβ-lactam regimen compared to an aminoglycoside/β-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients
✍ Jai H. Joshi; Kathryn A. Newman; Bary W. Brown; Rebecca S. Finley; Robert L. Rux 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 824 KB

In a prospective, randomized trial, 205 febrile episodes in granulocytopenic cancer patients were treated with ceftazidime with or without tobramycin (C +/- T), both agents being administered only if the initial granulocyte count was below 200/microliters, or ceftazidime plus piperacillin (C + P). T